Tech Company Financing Transactions
Arcturus Therapeutics Funding Round
Private investors participated in a $5 million Series A capital raise for Arcturus Therapeutics. This venture round was announced on 10/21/2013.
Transaction Overview
Company Name
Announced On
10/21/2013
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
Proceeds Purpose
The Series A funding, which comprised more than 90% of the Series Seed investors, will enable Arcturus to maintain its momentum, nominate its first clinical candidate in 2014, and recruit high caliber talent to expand its operations at the respected Janssen Labs in La Jolla, Calif.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10628 Science Ctr. Dr. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Arcturus Therapeutics is focused on developing novel RNA therapeutics for the treatment of various diseases aiming on Rare Diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Payne
Chief Financial Officer
Andrew Sassine
Chief Operating Officer
Padmanabh Chivukula
Browse more venture capital transactions:
Prev: 10/21/2013: Puralytics venture capital transaction
Next: 10/21/2013: LISNR venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs